Ivo Kohler

Affiliations: 
University of Innsbruck, Innsbruck, Tirol, Austria 
Area:
Visual perception
Google:
"Ivo Kohler"
Mean distance: 14.4 (cluster 29)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Neuber K, Steinrücke K, Kowalzick L, et al. (1995) Cytokine-mediated effects of peripheral blood mononuclear cells from patients with atopic eczema on keratinocytes (HaCaT) in a new coculture system. The British Journal of Dermatology. 133: 750-6
Thieler H, Kohler I, Achenbach H, et al. (1995) Further advances of chronic renal replacement therapy in eastern Germany, 1994 versus 1989. Clinical Nephrology. 44: 108-12
Kowalzick L, Kleinheinz A, Weichenthal M, et al. (1995) Low dose versus medium dose UV-A1 treatment in severe atopic eczema. Acta Dermato-Venereologica. 75: 43-5
Kowalzick L, Kleinheinz A, Neuber K, et al. (1995) Elevated serum levels of soluble adhesion molecules ICAM-1 and ELAM-1 in patients with severe atopic eczema and influence of UVA1 treatment. Dermatology (Basel, Switzerland). 190: 14-8
Kowalzick L, Neuber K, Weichenthal M, et al. (1994) Elevated serum-soluble ELAM-1 levels in patients with severe plaque-type psoriasis. Archives of Dermatological Research. 286: 414-6
Haeusler G, Guchev Z, Köhler I, et al. (1993) Constitutional chromosome anomalies in patients with cerebral gigantism (Sotos syndrome). Klinische PäDiatrie. 205: 351-3
Kowalzick L, Bildau H, Neuber K, et al. (1993) Clinical improvement in psoriasis during dithranol/UVB therapy does not correspond with a decrease in elevated serum soluble ICAM-1 levels. Archives of Dermatological Research. 285: 233-5
Kowalzick L, Kohler I, Meissner K. (1993) Influence of PUVA-treatment on serum levels of soluble interleukin-2 receptor in patients with cutaneous T-cell lymphoma (Mycosis fungoides) and psoriasis European Journal of Dermatology. 3: 219-222
Kowalzick L, Kohler I, Meissner K. (1993) Serum soluble interleukin 2-receptor levels during photochemotherapy in patients with cutaneous T-cell lymphoma (CTCL) and psoriasis | SERUM-SPIEGEL VON LOSLICHEM INTERLEUKIN-2-REZEPTOR WAHREND PUVA-BEHANDLUNG VON PATIENTEN MIT PSORIASIS UND MYCOSIS FUNGOIDES Aktuelle Dermatologie. 19: 202-205
Waldow SM, Lobraico RV, Kohler IK, et al. (1987) Photodynamic therapy for treatment of malignant cutaneous lesions. Lasers in Surgery and Medicine. 7: 451-6
See more...